Computational immunology is an interdisciplinary field that leverages computational and mathematical approaches to analyze complex immune system dynamics, understand immunological processes, and predict immune responses. This field plays a crucial role in advancing our understanding of immune system function, host-pathogen interactions, and the development of immune-related disorders. Using computational models, bioinformatics, and data-driven techniques, computational immunologists analyze large-scale biological data, such as genomics, proteomics, and high-throughput sequencing data. These approaches help identify patterns, pathways, and potential biomarkers associated with immune responses and diseases. Computational immunology contributes to vaccine design, drug development, and personalized medicine by simulating immune responses, predicting antigen-antibody interactions, and optimizing treatment strategies. Machine learning and artificial intelligence techniques are increasingly employed to analyze complex immunological datasets and make predictions. This field also facilitates the integration of diverse data sources, aiding in the discovery of novel immunological insights. Computational models help simulate immune responses in various scenarios, contributing to our ability to understand and predict the outcomes of different immunotherapies. As computational immunology continues to evolve, it serves as a powerful tool for unraveling the intricacies of the immune system, accelerating discoveries in immunological research, and informing the development of innovative strategies for diagnosing and treating immune-related disorders.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India